Status:
COMPLETED
Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Covid19
Lung Ultrasound
Eligibility:
All Genders
18+ years
Brief Summary
Covid-19 (English acronym meaning coronavirus disease 2019) is an emerging infectious disease caused by a strain of coronavirus called SARS-CoV-2. The current pandemic has resulted in a significant nu...
Eligibility Criteria
Inclusion
- patients admitted to ER for suspicion of COVID-19 infection who has a SARS-CoV-2 RT-PCR test and for whom the emergency doctor decide to perform a lung ultrasound as part of the BLUE protocol
- Age\> 18 years old
Exclusion
- patients \< 18 years of age
- patients under guardianship or curators
- pregnancy
- poor echogenicity due to the presence of an acoustic barrier (pneumothorax, subcutaneous emphysema, etc.)
- patients with a suspected or proven acute lung disease (pneumonitis, acute respiratory distress syndrome (ARDS))
- patients with chronic interstitial lung disease
- patients who will refuse to give their consent.
Key Trial Info
Start Date :
December 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 28 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04666064
Start Date
December 10 2020
End Date
April 28 2021
Last Update
July 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BAR
Amiens, France, 80054